Xiang ML - Search Results

1

An integrated scheme for feature selection and parameter setting in the support vector machine modeling and its application to the prediction of pharmacokinetic properties of drugs.

Yang SY, Huang Q, Li LL, Ma CY, Zhang H, Bai R, Teng QZ, Xiang ML, Wei YQ. Yang SY, et al. Among authors: xiang ml. Artif Intell Med. 2009 Jun;46(2):155-63. doi: 10.1016/j.artmed.2008.07.001. Epub 2008 Aug 12. Artif Intell Med. 2009. PMID: 18701266

2

Free energy profiles for monomer capture in Grubbs- and SHOP-type olefin polymerization catalysts: a constraint ab initio molecular dynamics study.

Yang SY, Xiang ML, Chen LJ, Xie GB, Shi B, Wei YQ, Ziegler T. Yang SY, et al. Among authors: xiang ml. J Comput Chem. 2007 Jan 30;28(2):513-8. doi: 10.1002/jcc.20572. J Comput Chem. 2007. PMID: 17186485

3

Detailed conformational dynamics of juxtamembrane region and activation loop in c-Kit kinase activation process.

Zou J, Wang YD, Ma FX, Xiang ML, Shi B, Wei YQ, Yang SY. Zou J, et al. Among authors: xiang ml. Proteins. 2008 Jul;72(1):323-32. doi: 10.1002/prot.21928. Proteins. 2008. PMID: 18214972

4

[Progress in the design of selective ATP-competitive kinase inhibitors].

Deng XQ, Xiang ML, Jia R, Yang SY. Deng XQ, et al. Among authors: xiang ml. Yao Xue Xue Bao. 2007 Dec;42(12):1232-6. Yao Xue Xue Bao. 2007. PMID: 18338633 Review. Chinese.

5

Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors.

Deng XQ, Wang HY, Zhao YL, Xiang ML, Jiang PD, Cao ZX, Zheng YZ, Luo SD, Yu LT, Wei YQ, Yang SY. Deng XQ, et al. Among authors: xiang ml. Chem Biol Drug Des. 2008 Jun;71(6):533-9. doi: 10.1111/j.1747-0285.2008.00663.x. Epub 2008 Apr 10. Chem Biol Drug Des. 2008. PMID: 18410307

6

Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method.

Ma CY, Yang SY, Zhang H, Xiang ML, Huang Q, Wei YQ. Ma CY, et al. Among authors: xiang ml. J Pharm Biomed Anal. 2008 Aug 5;47(4-5):677-82. doi: 10.1016/j.jpba.2008.03.023. Epub 2008 Mar 28. J Pharm Biomed Anal. 2008. PMID: 18455346

7

In silico prediction of mitochondrial toxicity by using GA-CG-SVM approach.

Zhang H, Chen QY, Xiang ML, Ma CY, Huang Q, Yang SY. Zhang H, et al. Among authors: xiang ml. Toxicol In Vitro. 2009 Feb;23(1):134-40. doi: 10.1016/j.tiv.2008.09.017. Epub 2008 Oct 2. Toxicol In Vitro. 2009. PMID: 18940245

8

Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors.

Zhang H, Xiang ML, Zhao YL, Wei YQ, Yang SY. Zhang H, et al. Among authors: xiang ml. Eur J Pharm Sci. 2009 Mar 2;36(4-5):451-7. doi: 10.1016/j.ejps.2008.11.014. Epub 2008 Dec 11. Eur J Pharm Sci. 2009. PMID: 19124075

9

Three-class classification models of logS and logP derived by using GA-CG-SVM approach.

Zhang H, Xiang ML, Ma CY, Huang Q, Li W, Xie Y, Wei YQ, Yang SY. Zhang H, et al. Among authors: xiang ml. Mol Divers. 2009 May;13(2):261-8. doi: 10.1007/s11030-009-9108-1. Epub 2009 Jan 31. Mol Divers. 2009. PMID: 19184630

10

Novel thienopyridine derivatives as specific anti-hepatocellular carcinoma (HCC) agents: synthesis, preliminary structure-activity relationships, and in vitro biological evaluation.

Zeng XX, Zheng RL, Zhou T, He HY, Liu JY, Zheng Y, Tong AP, Xiang ML, Song XR, Yang SY, Yu LT, Wei YQ, Zhao YL, Yang L. Zeng XX, et al. Among authors: xiang ml. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6282-5. doi: 10.1016/j.bmcl.2010.08.088. Epub 2010 Aug 21. Bioorg Med Chem Lett. 2010. PMID: 20846862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters